Cargando…
EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Myelodysplastic Syndromes
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878736/ https://www.ncbi.nlm.nih.gov/pubmed/35233507 http://dx.doi.org/10.1097/HS9.0000000000000695 |
| _version_ | 1784658730960289792 |
|---|---|
| author | van de Loosdrecht, Arjan A. Mandac Smoljanović, Inga |
| author_facet | van de Loosdrecht, Arjan A. Mandac Smoljanović, Inga |
| author_sort | van de Loosdrecht, Arjan A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8878736 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88787362022-02-28 EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Myelodysplastic Syndromes van de Loosdrecht, Arjan A. Mandac Smoljanović, Inga Hemasphere Editorial Lippincott Williams & Wilkins 2022-02-24 /pmc/articles/PMC8878736/ /pubmed/35233507 http://dx.doi.org/10.1097/HS9.0000000000000695 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial van de Loosdrecht, Arjan A. Mandac Smoljanović, Inga EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Myelodysplastic Syndromes |
| title | EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Myelodysplastic Syndromes |
| title_full | EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Myelodysplastic Syndromes |
| title_fullStr | EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Myelodysplastic Syndromes |
| title_full_unstemmed | EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Myelodysplastic Syndromes |
| title_short | EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Myelodysplastic Syndromes |
| title_sort | eha endorsement of esmo clinical practice guidelines for diagnosis, treatment, and follow-up for myelodysplastic syndromes |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878736/ https://www.ncbi.nlm.nih.gov/pubmed/35233507 http://dx.doi.org/10.1097/HS9.0000000000000695 |
| work_keys_str_mv | AT vandeloosdrechtarjana ehaendorsementofesmoclinicalpracticeguidelinesfordiagnosistreatmentandfollowupformyelodysplasticsyndromes AT mandacsmoljanovicinga ehaendorsementofesmoclinicalpracticeguidelinesfordiagnosistreatmentandfollowupformyelodysplasticsyndromes |